NBIX
Neurocrine Biosciences·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
NBIX fundamentals
Neurocrine Biosciences (NBIX) released its earnings on Oct 28, 2025: revenue was 794.90M (YoY +27.78%), beat estimates; EPS was 2.17 (YoY +19.89%), beat estimates.
Revenue / YoY
794.90M
+27.78%
EPS / YoY
2.17
+19.89%
Report date
Oct 28, 2025
NBIX Earnings Call Summary for Q3,2025
- Revenue Growth: Q3 net sales of $790 million (+28% YoY), driven by INGREZZA ($687M) and CRENESSITY ($98M).
- Sales Force Expansion: $150M+ investment in 2026 to accelerate growth, targeting psychiatry/neurology for INGREZZA and community endocrinologists for CRENESSITY.
- Pipeline Momentum: Phase III enrollment on track for osavampator (MDD) and direclidine (schizophrenia); valbenazine (DCP) Q4 readout.
- Financial Strength: $2.1B cash, Non-GAAP EPS of $1.08, and <20% gross to net for CRENESSITY.
- Strategic Focus: IRA preparation, R&D productivity (4 Phase I, 2 Phase II studies), and 2026-2029 TD market expansion.
EPS
Revenue
Revenue & Expenses
NBIX has released its 2025 Q3 earnings report, with revenue of 794.90M, reflecting a YoY change of 27.78%, and net profit of 209.50M, showing a YoY change of 61.40%. The Sankey diagram below clearly presents NBIX's revenue sources and cost distribution.
Key Indicators
Neurocrine Biosciences (NBIX) key financial stats and ratios, covering profitability, financial health, and leverage.
Neurocrine Biosciences (NBIX)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Neurocrine Biosciences (NBIX)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Neurocrine Biosciences (NBIX)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Neurocrine Biosciences (NBIX) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Neurocrine Biosciences (NBIX) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is the market's earnings forecast for Neurocrine Biosciences next quarter?What were the key takeaways from Neurocrine Biosciences's earnings call?Did Neurocrine Biosciences beat or miss consensus estimates last quarter?What were the key takeaways from Neurocrine Biosciences’s earnings call?What does Neurocrine Biosciences do and what are its main business segments?What is Neurocrine Biosciences's latest dividend and current dividend yield?What is Neurocrine Biosciences's gross profit margin?What factors drove the changes in Neurocrine Biosciences's revenue and profit?
